Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-11

Clinical Trial Update: Real-Life Evidence on Stroke Prevention in SPAF

View source ↗

Summary

A Bayer-sponsored trial providing real-world evidence on stroke prevention in patients with atrial fibrillation has completed. The update summarizes real-world …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation (Prevention of Stroke) | Status: COMPLETED